Alessandra Pavesio - Feb 10, 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: SVP & CHIEF SCIENCE OFFICER
Signature: /s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol: BVS
Transactions as of: Feb 10, 2022
Transactions value $: $952,025
Form type: 4
Date filed: 2/14/2022, 07:43 PM
Next filing: Feb 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Options Exercise		+192K	+19170.8%		193K	Feb 10, 2022	Direct	F1
transaction	BVS	Class A Common Stock	Tax liability	$952K	+73.9K	+164.7%	$12.88	119K	Feb 10, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BVS	Phantom Profit Units	Options Exercise	$0	-192K	-100%	$0.00^*	0	Feb 10, 2022	Class A Common Stock	192K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.